Latest Breaking News On - ஒன்றுபட்டது கிஂக்டம் எதிர்கால - Page 4 : comparemela.com

May 01 2021 Read 4 Times University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund, to support the development of its novel stem cell therapy to treat sensorineural hearing loss (SNHL). The company’s underlying technology is based on innovative research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield. It seeks to reverse SNHL through the repair of the damaged cytoarchitecture in the inner ear.  SNHL happens when there is damage to the hair cells in the cochlea and/or to the auditory nerve. There are currently no pharmacological treatments available for SNHL despite the increasing number of patients that suffer from this condition globally.

United kingdomMarcelo rivoltaSimon chandlerFrank kalkbrennerUnited kingdom government future fundBoehringer ingelheim venture fundUnited kingdom future fundUniversity of sheffieldRinri therapeuticsProfessor marcelo rivoltaUnited kingdom futureGlobal headஒன்றுபட்டது கிஂக்டம்சிமோன் சாண்ட்லர்ஒன்றுபட்டது கிஂக்டம் அரசு எதிர்கால நிதிபோஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி